Clinical Trial Update: Effect of Remazolam Besylate Combined With Remifentanil Analgesic Sedation on the Prognosis of Patients With Sepsis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining whether combining Remazolam Besylate with Remifentanil analgesia affects prognosis in patients with sepsis; enrollment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Remazolam Besylate (remazolam besylate)
• Remifentanil (remifentanil)

Snippet

Sponsor: First Affiliated Hospital of Ningbo University | Conditions: Sepsis | Phase 4 | Status: ENROLLING_BY_INVITATION